During the pandemic medical device manufacturers may have qualified for reduced requirements under the Emergency Use Authorization (EUA). The FDA has now published draft guidance for the transition back to full regulatory compliance. The document addresses the EUA transition plan for manufacturers to achieve compliance, and what is required for manufacturers who no longer plan to produce the device after the EUA has ended.

Click here to read the FDA draft guidance.